Lithium (Li) is still useful in the treatment of bipolar disorder. Cellular mechanisms of Li action are not fully understood and include some cytoprotective properties. Data concerning Li effect on the apoptotic mechanisms in cells other than neurons are fragmentary and contradictory. We have investigated anti-apoptotic activity of Li in a lymphoid derived MOLT-4 cell line. Spontaneous and camptothecin-induced apoptosis was analyzed in cells treated with 0-20 mM Li carbonate. Early apoptosis was identified as significant mitochondrial depolarization (JC-1 staining). Later stages of apoptosis were estimatied with annexin V binding and by the proportion of cells containing sub-G1 amounts of DNA (PI staining). We have observed a biphasic effect of Li on the proportion of spontaneously apoptotic cells;namely, low (therapeutic) concentrations of Li had a significant effect stabilizing the mitochondrial membrane polarization, while 10 and 20mM Li increased apoptosis. The latter could be seen both as mitochondrial depolarization as well as an increased proportion of sub-G1 cells, accompanied by reduced proportion of S phase cells. Li at concentrations above 2 mM had a significant, dosedependent, anti-apoptotic effect on the cells undergoing camptothecin induced apoptosis. In conclusion, demonstrated cytoprotective effect of Li is at least partially related to stabilization of mitochondrial membrane potential and to the reduction of DNA damaging effects in proliferating cells; both may form part of the mechanism through which Li is useful in therapy of bipolar disorder, but may have more general consequences.
Introduction
Lithium (Li) is the 'gold standard' for the prophylaxis of bipolar affective disorder (BPD), a disease which is characterized by recurrent episodes of mania and depression accompanied by changes in psychovegetative function, cognitive performance, and general health.
Although Li preparations have been used for over 50 years, the cellular mechanisms of its action and how it exerts its therapeutic effect remain not fully understood. The pathophysiology of BPD is complex and still unclear but Li seems to target at least several abnormalities observed in mood disorders. Substituting for sodium, Li stabilizes numerous cellular processes [1] . It has a direct influence on signal transduction by modulating second messengers synthesis. Li was also shown to modulate glutaminergic and GABA-ergic neurotransmission [2, 3] .
Mood disorders are not only neurotransmission defects but are linked with structural changes of the nervous system and profound rearrangements in other integrative systems of the body [4] . More and more glial, neuroendocrine and immunologic dysfunctions seem to be recognised as contributing to mood disorders' pathogenesis [5] [6] [7] [8] . In this context possible cytoprotective capacity of lithium salts, although debated, seems very promising for both neuron and glial regeneration and for possible preservation of the intact function of the immune cells [9] [10] [11] [12] .
Cytoprotective effects of Li are mainly attributed to: (1) increasing amounts of cytoprotective proteins such as Bcl-2 and decreasing proapoptotic proteins -Bax and p53, (2) inhibition of glycogen synthetase kinase-3 (GSK-3) and (3) protein kinase C (PKC) activation [9, [13] [14] [15] [16] . Thus, it is conceivable that affecting the same mechanisms of survival or death Li + may exert a cytoprotective effect on other cell types. However, available data concerning the mechanisms of Li effects on cells other than neurons including the immune system cells are fragmentary and contradictory [7, 9, [17] [18] [19] [20] [21] [22] [23] [24] . In this work we have tested the hypoth-esis of the general anti-apoptotic activity of Li salts in non-neuronal cells of lymphoid derivation.
Materials and methods
MOLT-4 cells were a courteous gift of Medical Chemistry Department, Medical University of Gdañsk. Cell culture media, antibiotics (penicillin/streptomycin) and fetal bovine serum (FBS), lithium carbonate (Li2CO3), campthotecin, Hoechst 33342, 5,5',6,6'tetrachloro-1,1',3,3' tetraethylbenzimidazolycarbocyanine iodide (JC-1), RNAse, propidium iodide (PI) and Tween were purchased from Sigma-Aldrich (Germany). Annexin-V-FLUOS Staining Kit was from Roche and all the cytometry consumables were from BD Biosciences (Belgium).
Cell culture and drug treatment. Cells were cultured at 37 °C in RPMI medium supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin in a 95% air, 5% CO 2 humidified incubator. Cells were seeded at 0.5 × 10 6 cells per ml in 24 well plates and grown without or with Li carbonate added to the final concentration of 0.5 μM; 1 μM; 1.5 μM (as equivalent of the therapeutic Li concentrations) and 2 μM;10 and 20 μM, in the presence or absence of 1 μg/ml of campthotecin for 4, 24, 48 and 72 hours. At times specified cells were harvested, washed with PBS and immediately further processed. Early apoptosis was identified as significant mitochondrial depolarization of cells stained with fluorescent mitochondrial potential cyanine probe JC-1 [25] [26] [27] , while later stages of apoptosis by estimation of annexin V binding and by detection of cells containing sub-G1 amounts of DNA by staining with propidium iodide (PI) [28] [29] [30] . Apoptotic cell morphology was visualised with a DNA binding dye -Hoechst 33342 [31] .
Mitochondrial potential changes. In order to detect the mitochondrial depolarization as an early feature of the incipient apoptosis, cells were incubated with 10 µg/mL 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl-carbocyanine iodide (JC-1) for 15 minutes at room temperature and their green and red fluorescence corresponding to JC-1 monomers and aggregates respectively was assessed by FACS. Cells exhibiting an increase of green fluorescence as compared to the control were considered to have their mitochondria depolarized.
Annexin V binding. Later stage of apoptotic process, the membrane symmetrization leading to the externalization of the phosphatidylserine was assessed by Annexin V binding, while late apoptotic and necrotic cells were excluded by simultaneous PI staining using the Annexin-V-FLUOS Staining Kit (Roche). Cells were suspended in the binding buffer and incubated with FITCconjugated annexin V and PI for 15 minutes at room temperature, then immediately analyzed by FACS.
Cell cycle and apoptosis analysis by DNA content. Latest stages of apoptosis leading to depletion of apoptotic cells of their DNA, as well as the proportion of cells in various phases of the cell cycle (G1, S, G2/M) were assessed after staining cellular DNA with the PI. Cells were fixed with ice cold ethanol, washed and incubated with the staining mixture containing Tween-20, RNAse and PI for 15 minutes at 37°C, then analyzed by FACS. All cytometric analyses were performed using the FACScan flow cytometer (BD Biosciences). Raw data were acquired with dedicated CellQuest software (BD Biosciences) and analyzed with WinMDI 2.9 (J. Trotter;The Scripps Institute).
Hoechst 33342 staining. Harvested cells were stained with 5 μg/ml Hoechst 33342 in PBS. Stained cells were transferred onto microscopic slides and analyzed under the fluorescence microscope Eclipse TS100 (Nikon) with the 400-420 nm bypass filter. Photographs were collected using NIS Elements Nikon software.
Statistical analysis. All statistical analyses were performed with Statistica 7.1 software under the Medical University of Gdañsk license agreement. P-values of ≤0.05 were taken to be significant in all tests. 
Results
There were significant differences in the effect of Li salt on the various stages of the apoptotic process, depending on its being spontaneous or camptothecininduced.
First, we have observed a mildly proapoptotic effect of Li on the proportion of spontaneously apoptotic MOLT-4 cells assessed by the mitochondrial depolarization, where the proportion of depolarized cells started to rise at 1 mM Li + and then rose proportionally to the concentration of lithium salt, reaching significant difference from the untreated control ( Fig.  1 A) . This effect was generally paralleled by the appearance of apoptotic, Annexin V -binding cells upon treatment with 10 mM Li + (Fig. 1 B) .
Interestingly, the effect exerted by Li + over MOLT-4 cells induced to undergo apoptosis by treatment with the topoisomerase II inhibitor, camptothecin, was clearly biphasic. Namely, low (therapeutic) concentrations of Li + had a significant effect stabilizing the mitochondrial membrane potential (Fig. 1 C) and decreasing the external surface binding of Annexin V ( Fig. 1 D) , while 10 mM Li + increased the proportion of early apoptotic cells enumerated both ways above the control (untreated) level ( Fig. 1 C, D) .
Also the effect of Li + on late apoptosis (cellular DNA fragmentation and removal) depends on its concentration and on the manner of apoptosis induction. Thus, in the untreated cells, only the supraclinical (10 and 20 mM) concentrations of Li + induced significant apoptosis as judged by the appearance of cells containing sub-G1 amounts of DNA ( Fig. 2 A-C, Fig. 3  A) .
Increased proportion of sub-G1 cells appearing due to Li + treatment was accompanied by reduced proportion of S phase cells, but this effect showed only after 24 hour treatment ( Fig. 3 B) and disappeared after 48 hours of incubation with Li + , at which time the proportion of sub-G1 cells in 10 and 20 mM Li + -treated samples did not differ from that seen after 24 hours ( Fig. 3 C, D) .
Interestingly enough, while the effect on Li + in untreated cells was rather pro-apoptotic, that exerted over the MOLT-4 cells in which apoptosis was induced by camptothecin (blockade of topoisomerase), was clearly anti-apoptotic and cytoprotective. This effect could be demonstrated for all three phases of induced apoptosis. Thus, Li + at 0.5-2 mM significantly decreased the proportion of cells that exhibited mitochondrial depolarization (Fig. 1 C) of Annexin V -biding cells (Fig. 1 D) . On the other hand, appreciable and significant effect of Li + preventing the formation of sub-G1 cells could be seen only at 10 and 20 mM of lithium salt, after both 24 and 48 hour treatment (Fig. 2 D-F, Fig. 4 A, C) . Some concentration dependency of the anti-apoptotic effect of Li + on camptothecin-treated cells could also be seen;thus, 2 mM Li + had no protective effect, while that of 20 mM Li + was significantly higher than that exerted by 10 mM Li + (Fig. 4) . Accordingly, morphological changes in the nuclei of MOLT-4 cells treated with either Li + or camptothecin only, or with their combination, could be seen. Thus, treatment with Li + only did not change the proportion of apoptotic cells displaying fragmented, focally condensed chromatin ( Fig. 5 A, B) , while treatment with camptothecin only resulted in the vast majority of the cells to become morphologically apoptotic, as judged by Hoechst 33342 staining ( Fig. 5 C) . Finally, 20 mM Li + added simultaneously with camptothecin completely abolished its proapoptotic level ( Fig. 5 D) .
Similarly to the effects of Li + on the proportions of otherwise untreated sub-G1 and S phase cells, also the Li + -dependent reduction of sub-G1 fraction of MOLT-4 cells treated with camptothecin was reciprocated by a significant increase in the proportion of cells in Sphase of the cycle (Fig. 2 F, Fig. 4 B) . Unlike in the case of untreated cells, the effect was preserved also in the cells that were treated with Li + and camptothecin over 48 hours (Fig. 4 D) .
Discussion
We have demonstrated here a variable, dose dependent effect of treatment with therapeutic and supratherapeutic doses of lithium salts on the survival and spontaneous and camptothecin-induced apoptosis of MOLT-4 cells. Thus, in otherwise untreated cells, Li + acted mostly pro-apoptotically, and that mainly at supratherapeutic concentrations above 2 mM, while in the case of camptothecin-induced apoptosis, therapeutic Li + concentrations were anti-apoptotic and thus cytoprotective. These effects were seen by any means of apoptosis assessment, including initial mitochondrial depolarization (JC-1 monomer fluorescence), membrane symmetrization (Annexin V binding) and DNA fragmentation/loss, suggesting that Li + is either directly or indirectly affecting all of them.
The process of apoptosis is controlled by a diverse range of cell signals, which may originate extracellularly or intracellularly. There are two main apoptosis pathways:(1) internal (mitochondrial) with caspase-9 playing the main role and (2) Fas or TNF receptor induced with central role of caspase-8. A number of proapoptotic and cytoprotective proteins take part in apoptosis regulation. In response to apoptosis-inducing signals p53 regulates concentrations of some of them. Level of Bax protein increases and of Bcl-2 decreases. Bcl-2/Bax ratio in the mitochondria determines the release of cytochrome c leading to apoptosome formation. The apoptosome consists of cytochrome c, Apaf-1 protein and procaspse-9 and its formation activates caspase cascade leading the cell to apoptosis [31] [32] [33] . Thus, the mechanisms of both proand anti-apoptotic Li + activity seen by us may be complex.
Concerning its modulation of the mitochondrial potential, Li + is known to substitute for Na + , and to accumulate in the cell displacing intracellular Na and in turn also intracellular Ca [1] . Thus, substitution of sodium ions by Li stabilizes numerous intracellular processes and may be responsible for its action on mitochondria [2] .
Chronic Li administration has been reported to induce a robust elevation in the levels of the cytoprotective protein Bcl-2 when measured in the frontal cortex, hippocampus, and striatum. Elevated Bcl-2 not only protects the neurons from apoptosis but has also been proven to result in better axonal regeneration in mammals [34] [35] [36] [37] . In rabbits, pretreatment with lithium prevented aluminum-induced cytochrome c translocation and thus initiation of apoptosis [38] . Li can also induce decrease in Bax and p53 proteins and inhibits procaspase-3 cleavage to caspase-3 [38] . The latter is supported by the observation that Li prevents apoptosis evoked by different substances including colchicine exerting its action through caspase-3 activation [39] [40] [41] , which in fact agrees with our observations.
Li also influences glycogen metabolism which is involved in cell proliferation, differentiation and apoptosis [42, 43] . GSK-3 causes phosphorylation which inhibits glycogen synthase, simultaneously glycogenolysis is activated. GSK-3 has numerous cellular targets, namely transcription factors, cytoskeleton proteins and cell division involved molecules including AP-1, cyclic AMP response element binding protein (CREB), heat shock factor-1, nuclear factor of activated T cells NF-AT, c-Myc, beta-catenin, CCAAT/ enhancer binding protein, and NF?B. Generally, active GSK-3 is proapoptotic and its inhibition is antiapoptotic [44, 45] . Li inhibits GSK-3 both directly (substituting for cofactory magnesium ions) and indirectly. Other changes resulting from Li-induced GSK-3 inhibition were shown in proliferating thyreocytes, namely an increase in Jun bound to DNA, CREB activity reduction and lower MAP1B and Tau phosphorylation [46] [47] [48] [49] . Wnt glycoproteins, belonging to the pathway activated by the GSK-3 inhibition (e.g. resulting from lithium treatment), are involved in embryogenesis, stem cell development, cell proliferation and axonal plasticity [50] . In the absence of Wnt, GSK-3 phosphorylates beta-catenins leading to their degradation, which is prevented by Li + . Beta-catenins, accumulating in the cell nuclei when GSK-3 is inhibited, bind with T-cell-specific transcription factor (TCF) and activate a number of genes, possibly involved in the cell survival [46, 47] .
Another proposed Li action is through protein kinases which catalyse phosphorylation of the target proteins and subsequently take part in the regulation of the cell respose to the stimuli. Li treatment leads to diacyloglycerol (DAG) accumulation and activation of the protein kinase C (PKC) [46] . PKC targets two proteins, both involved in neuroplasticity, GAP-43 (growth-associated protein) and MARCKS (myristoylated alanine rich C kinase substrate). In cerebellar granule cells Li has been shown to induce axonal remodeling resembling the changes seen with GAP-43 overexpression [46, 47, 51] .
A growing body of data suggests that bipolar disease BPD is not only a defect in neurotransmission mechanisms but arises from abnormalities in synaptic and neuronal plasticity cascades, leading to an aberrant information processing in critical synapses and circuits [3, 4, 12, 19] . Recent morphometric studies have been investigating potential structural brain changes in BPD, and there is evidence from a variety of sources demonstrating significant volume reductions in several regions of CNS, as well as regional decrease in the glia and neurons numbers and sizes [6, 52, 53] .
In this context reports of a possible cytoprotective capacities of Li have been enthusiastically welcomed immediately noting that it may be important not only in mood disorders but in neurodegenerative diseases. Modulating GSK-3 activity Li reduced amyloid and tau protein phosphorylation in transgenic mice, results very promising for the possible Li use for Alzheimer disease [10, 54, 55] .
Data regarding the neuroprotective action of Li have been recently reviewed, showing that although postulated by many has only been proven by few [9] . It may be in line with our observation that the cytoprotective effect of Li salts is dose dependent -in our model at therapeutic concentrations the spontaneous apoptosis is prevented, while higher concentrations prove toxic and increase apoptosis. Interestingly, significant anti-apoptotic effect in capthotecin-induced model is achieved with either the therapeutic (for early stages of apoptosis, including the mitochondrial depolarization and membrane symmetrization) or supratherapeutic concentrations of lithium salts (which result in protection from DNA fragmentation and loss). Thus experimental data must be interpreted with caution before conclusions are drawn about the effect in humans in vivo.
Li administration was recently linked to reduced tumor incidence compared to the general population [56] . It was shown to reduce proliferation in tumors expressing high activity of GSK-3. In prostate cancer Li decreases the expression of multiple DNA replication-related genes, including cyclin A, cyclin E, cell division cycle 6 (cdc6), and cdc25C, all regulated by GSK-3 dependent E2 factor during the cell cycle [56, 57] .
In the light of our observations showing that the treatment with Li + not only reduced the camptothecininduced apoptosis, but in fact increased the proportion of cells in the S phase of the cycle, it is also important to stress, that shown cytoprotective properties of Li, while very welcomed in some cases, might not be desirable during cytostatic treatment [58] [59] [60] [61] [62] . Our research clearly indicates that topoisomerase inhibitor treatment might be severely jeopardized by simultaneous administration of the Li salts. Thus, in our opinion, safety of lithium treatment during chemotherapeutic intervention should be considered and needs further evaluation.
Concluding, both the recent papers cited above and our observations presented herein suggest that 
